MAPT and Alzheimer disease: Alzheimer's disease (AD) is characterized clinically by progressive cognitive decline and neuropathologically by the accumulation of amyloid β (Aβ) peptides in extracellular plaques and hyperphosphorylated tau protein in intraneuronal tangles in the brain [1].